MIC + L-Carnitine + B12 vs Semaglutide
A side-by-side research comparison of MIC + L-Carnitine + B12 and Semaglutide across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | MIC + L-Carnitine + B12 | Semaglutide |
|---|---|---|
| Full name | Lipotropic Injection Blend (Methionine, Inositol, Choline + L-Carnitine + B12) | Semaglutide (GLP-1 Receptor Agonist) |
| Category | Weight Management | Weight Management |
| Status | Compounded medication | FDA Approved |
| Mechanism | Methionine aids fat breakdown and detoxification. Inositol helps redistribute body fat and improves insulin signaling. Choline prevents fat deposits in the liver. L-Carnitine shuttles fatty acids into mitochondria for oxidation. B12 supports energy metabolism and red blood cell formation. | Binds GLP-1 receptors in the pancreas to stimulate insulin secretion, in the brain to reduce appetite, and in the GI tract to slow gastric emptying. 94% homology to native GLP-1. |
| Molecular weight | Blend (multiple active compounds) | 4,114 Da |
| Half-life | Variable by component; B12 ~6 days, L-Carnitine ~17 hours | 7 days (168 hours) |
| Bioavailability | ~100% (intramuscular injection) | High (SubQ ~89%), Moderate (oral ~1% with SNAC) |
| Typical dose | 1 mL injection (standardized blend) | 0.25 mg → titrate up to 2.4 mg |
| Frequency | 1-2x weekly | Once weekly |
| Route | Intramuscular injection | Subcutaneous injection |
MIC + L-Carnitine + B12 reported benefits
- Enhanced fat metabolism
- Increased energy levels
- Liver support and detoxification
- Improved mood and mental clarity
- Support for B12 deficiency
Semaglutide reported benefits
- Significant weight loss (15-17%)
- Improved glycemic control
- Cardiovascular risk reduction
- Reduced food cravings
- Lower HbA1c
Related comparisons
Research and educational reference only. Not medical advice.